{"id":"opioids-taper-off","safety":{"commonSideEffects":[{"rate":null,"effect":"Withdrawal symptoms (anxiety, insomnia, muscle aches)"},{"rate":null,"effect":"Pain exacerbation during tapering"},{"rate":null,"effect":"Mood disturbances"}]},"_chembl":{"chemblId":"CHEMBL440626","moleculeType":"Small molecule","molecularWeight":"1268.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Opioid tapering is a clinical management strategy rather than a pharmacological agent. It involves systematically reducing opioid doses over time to allow the body to adjust and reduce physical dependence. This approach is used to transition patients away from chronic opioid therapy while managing pain through alternative modalities and minimizing acute withdrawal effects.","oneSentence":"A structured tapering protocol that gradually reduces opioid dosing to minimize withdrawal symptoms and dependence while managing pain.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:50:44.184Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic opioid use disorder with tapering to discontinuation"},{"name":"Chronic pain management with opioid dose reduction"}]},"trialDetails":[{"nctId":"NCT07221786","phase":"NA","title":"Preoperative Opioid Tapering Before Spine Surgery","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-12-01","conditions":"Opioid Consumption, Postoperative, Pain After Surgery, Opioid Dependency","enrollment":45},{"nctId":"NCT05980260","phase":"PHASE3","title":"Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach","status":"COMPLETED","sponsor":"HELP for NOWS Consortium","startDate":"2024-03-25","conditions":"Neonatal Opiate Withdrawal Syndrome","enrollment":626},{"nctId":"NCT05180669","phase":"NA","title":"Reward-based Technology to Improve OUD Treatment","status":"TERMINATED","sponsor":"Q2i, LLC","startDate":"2022-11-18","conditions":"Opioid Use Disorder","enrollment":41},{"nctId":"NCT07348627","phase":"PHASE3","title":"Opioid-Sparing Joint Replacement","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Pain Management, Opioid Consumption","enrollment":120},{"nctId":"NCT05511909","phase":"PHASE2","title":"Evaluating Buspirone to Treat Opioid Withdrawal","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-12-15","conditions":"Opioid Use Disorder, Opioid Withdrawal, Opioid Craving","enrollment":100},{"nctId":"NCT03303209","phase":"","title":"Patient-Centered Opioid Tapering Study","status":"COMPLETED","sponsor":"Stanford University","startDate":"2015-09-15","conditions":"Opioid Use, Chronic Pain","enrollment":51},{"nctId":"NCT04464980","phase":"PHASE2","title":"Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2021-06-08","conditions":"Opioid Use Disorder (OUD)","enrollment":1516},{"nctId":"NCT04827992","phase":"NA","title":"Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-08-23","conditions":"Opioid Use, Pain, Marijuana Use","enrollment":87},{"nctId":"NCT06574009","phase":"PHASE4","title":"Better Options for Chronic Cancer Pain","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-10-07","conditions":"Chronic Pain, Cancer Survivor, Opioid Dependence","enrollment":294},{"nctId":"NCT07158476","phase":"PHASE4","title":"Efficacy of Methylprednisolone for Pain Control After ACL Repair","status":"RECRUITING","sponsor":"St. Louis University","startDate":"2025-10-21","conditions":"ACL Surgery, Pain Management","enrollment":90},{"nctId":"NCT06027099","phase":"PHASE3","title":"CARES-Spine (Comprehensive Analgesic, Recovery, and Education Support for Spine Surgery) Trial","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-12-05","conditions":"Chronic Pain, Back Pain, Neck Pain","enrollment":375},{"nctId":"NCT05821699","phase":"NA","title":"Effect of Personalized Pain Coaches After Orthopaedic Surgery for Patients With Sports Medicine Injuries","status":"RECRUITING","sponsor":"Emory University","startDate":"2023-08-17","conditions":"Sports Medicine Injuries","enrollment":150},{"nctId":"NCT05573906","phase":"NA","title":"Benzodiazepine Taper With Cognitive Behavioral Therapy in Patients Using Prescription Opioids","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2023-04-13","conditions":"Anxiety Disorders","enrollment":42},{"nctId":"NCT05859269","phase":"PHASE4","title":"Methylprednisolone Taper After Total Knee Replacement","status":"COMPLETED","sponsor":"Emory University","startDate":"2023-10-16","conditions":"Knee Arthritis","enrollment":101},{"nctId":"NCT05027919","phase":"PHASE2","title":"Assessing a Clinically-meaningful Opioid Withdrawal Phenotype","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2021-12-01","conditions":"Opioid Withdrawal, Opioid Use Disorder, Opioid Craving","enrollment":60},{"nctId":"NCT05708521","phase":"PHASE4","title":"Personalization of Opioid Prescription Following Orthognathic Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2023-04-24","conditions":"Pain, Postoperative, Orthognathic Surgery, Opioid Use","enrollment":201},{"nctId":"NCT05788016","phase":"NA","title":"Developing an Opioid Taper Intervention Before Total Joint Arthroplasty","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2024-01-10","conditions":"Arthritis Knee, Arthritis Hip, Chronic Pain","enrollment":45},{"nctId":"NCT05097976","phase":"PHASE4","title":"Medrol Dosepak for Outpatient Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Rush University Medical Center","startDate":"2022-03-01","conditions":"Total Knee Arthroplasty","enrollment":420},{"nctId":"NCT05422014","phase":"NA","title":"Upper Extremity Life Care Specialist (LCS)","status":"RECRUITING","sponsor":"Emory University","startDate":"2022-10-17","conditions":"Upper Extremity Trauma","enrollment":80},{"nctId":"NCT04095624","phase":"NA","title":"Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion","status":"COMPLETED","sponsor":"Stanford University","startDate":"2019-09-09","conditions":"Opioid Use, Spine Fusion","enrollment":16},{"nctId":"NCT03445988","phase":"NA","title":"Cognitive Behavioral Therapy and Chronic Pain Self-Management Within the Context of Opioid Reduction: The EMPOWER Study","status":"COMPLETED","sponsor":"Stanford University","startDate":"2018-07-24","conditions":"Chronic Pain","enrollment":1462},{"nctId":"NCT03890263","phase":"NA","title":"Evaluating Chronic Pain Self-Management Support with an Opioid De-prescribing Intervention","status":"COMPLETED","sponsor":"Queen's University","startDate":"2019-07-01","conditions":"Chronic Pain","enrollment":24},{"nctId":"NCT04154384","phase":"NA","title":"Life Care Specialists (LCS) With a Focus on Patient Pain Management and Prevention of Substance Misuse","status":"COMPLETED","sponsor":"Emory University","startDate":"2020-02-21","conditions":"Opioid Use","enrollment":333},{"nctId":"NCT04070157","phase":"PHASE2","title":"Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal","status":"TERMINATED","sponsor":"USWM, LLC (dba US WorldMeds)","startDate":"2019-08-02","conditions":"Opioid Withdrawal (Disorder)","enrollment":4},{"nctId":"NCT04814992","phase":"NA","title":"Pre-op Cognitive Behavior Therapy to Decrease Chronic Post-Surgical Pain in TKA","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-10-01","conditions":"Chronic Post-Surgical Pain","enrollment":54},{"nctId":"NCT04218240","phase":"PHASE2","title":"Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-12-17","conditions":"Opioid Withdrawal","enrollment":90},{"nctId":"NCT04902547","phase":"NA","title":"Evaluation of a Patient-Centred, Multidisciplinary Opioid Tapering Program for Individuals With Chronic Non-Cancer Pain on Long Term Opioid Therapy","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2021-05-01","conditions":"Opioid Use, Opioids; Harmful Use, Hyperalgesia","enrollment":26},{"nctId":"NCT02790476","phase":"NA","title":"Behavioral Insights to Encourage Judicious Prescribing of Opioids","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2017-01-27","conditions":"Substance-Related Disorders","enrollment":851},{"nctId":"NCT03675386","phase":"NA","title":"Reducing Opioid Use for Chronic Pain Patients Following Surgery","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2018-09-24","conditions":"Chronic Pain, Opioid Use, Postoperative Pain","enrollment":210},{"nctId":"NCT03375216","phase":"NA","title":"Quantitative Sensory Testing in Chronic Pain Patients Undergoing Opioid Treatment and Opioid Tapering","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2017-12-22","conditions":"Analgesic Drug Dependence, Sensory Deficit","enrollment":43},{"nctId":"NCT04087109","phase":"NA","title":"MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study)","status":"WITHDRAWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2021-01-01","conditions":"Polypharmacy, Deprescribing, Adverse Drug Event","enrollment":""},{"nctId":"NCT04762537","phase":"NA","title":"Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2021-03-16","conditions":"Opioid-use Disorder","enrollment":415},{"nctId":"NCT04257695","phase":"NA","title":"Developing and Pilot Testing an Opioid Tapering Protocol","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2021-05-04","conditions":"Chronic Pain, Opioid Use, Analgesia","enrollment":2},{"nctId":"NCT03026790","phase":"PHASE2","title":"Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2017-10-19","conditions":"Chronic Pain","enrollment":820},{"nctId":"NCT05159362","phase":"NA","title":"Usability Testing for the Reward-based Technology to Improve OUD Treatment","status":"COMPLETED","sponsor":"Q2i, LLC","startDate":"2020-07-01","conditions":"Opioid-use Disorder, Contingency Management, Medication for Opioid-use Disorder","enrollment":26},{"nctId":"NCT03743402","phase":"NA","title":"Strategies to Improve Pain and Enjoy Life","status":"COMPLETED","sponsor":"University of Washington","startDate":"2019-04-04","conditions":"Chronic Pain","enrollment":153},{"nctId":"NCT03534102","phase":"PHASE4","title":"Can Simplified and More Detailed Instructions Affect Post-Operative Narcotic Consumption","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2022-06-06","conditions":"Opioid Use, Opioid Dependence, Knee Pain Chronic","enrollment":""},{"nctId":"NCT05250570","phase":"NA","title":"Distress Tolerance for Benzodiazepine Discontinuation","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2022-06-17","conditions":"Substance Use Disorders","enrollment":1},{"nctId":"NCT02737826","phase":"NA","title":"Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2016-05","conditions":"Chronic Pain, Opioid Pain Medication","enrollment":32},{"nctId":"NCT03232346","phase":"PHASE3","title":"A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2017-08-01","conditions":"Opioid-use Disorder","enrollment":11},{"nctId":"NCT02543944","phase":"PHASE2, PHASE3","title":"Improving Treatment Outcomes for Prescription Opioid Dependence","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2016-02","conditions":"Drug Dependence","enrollment":117},{"nctId":"NCT04963972","phase":"NA","title":"Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery","status":"UNKNOWN","sponsor":"Lucid Lane, Inc","startDate":"2021-02-23","conditions":"Malignant Abdominal Neoplasm, Malignant Head and Neck Neoplasm, Malignant Solid Neoplasm","enrollment":272},{"nctId":"NCT02363998","phase":"PHASE3","title":"Open-Label, Safety Study of Lofexidine","status":"COMPLETED","sponsor":"USWM, LLC (dba US WorldMeds)","startDate":"2015-02","conditions":"Opioid Withdrawal","enrollment":286},{"nctId":"NCT04109118","phase":"PHASE2","title":"Benzodiazepine Discontinuation in Opioid Agonist Therapy","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2021-03-18","conditions":"Substance Use Disorders","enrollment":4},{"nctId":"NCT03912298","phase":"","title":"Opioid Taper Study","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2019-04-15","conditions":"Chronic Pain","enrollment":7},{"nctId":"NCT04787692","phase":"NA","title":"Impact of Daily, Digital and Behavioral Tele-health Tapering Program for Perioperative Surgical Patients Exposed to Opioids and Benzodiazepines.","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-08-07","conditions":"Elective Spine Surgery Receiving Pre and/or Postoperative Pain Control With Opioids","enrollment":150},{"nctId":"NCT01843023","phase":"PHASE4","title":"Extended Release Naltrexone for Opioid-Dependent Youth","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2013-06","conditions":"Drug Dependence","enrollment":288},{"nctId":"NCT04198961","phase":"NA","title":"Electronic Intervention to Chronic Opioid Therapy","status":"COMPLETED","sponsor":"Stanford University","startDate":"2020-06-17","conditions":"Chronic Opioid Therapy","enrollment":43},{"nctId":"NCT05003596","phase":"PHASE2, PHASE3","title":"Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand","status":"UNKNOWN","sponsor":"Robert Wood Johnson Barnabas Health","startDate":"2021-09-01","conditions":"Hand Injuries, Finger Injuries","enrollment":60},{"nctId":"NCT03156907","phase":"PHASE2","title":"High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2017-09-15","conditions":"High Dosage Buprenorphine","enrollment":60},{"nctId":"NCT04275258","phase":"NA","title":"Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder","status":"UNKNOWN","sponsor":"University of Washington","startDate":"2020-06-01","conditions":"Opioid Use, Pain, Postoperative, Opioid Use, Unspecified","enrollment":100},{"nctId":"NCT03077932","phase":"NA","title":"An App to Aid in Transitioning Off Opioid Medication","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2016-04-01","conditions":"Opiate Use Disorder, Opiate Withdrawal Syndrome","enrollment":15},{"nctId":"NCT00472303","phase":"PHASE3","title":"A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2007-07","conditions":"Tumor, Pain","enrollment":622},{"nctId":"NCT03748862","phase":"","title":"The Effect of Primary Care Opioid Taper Plans on Sustained Opioid Taper","status":"COMPLETED","sponsor":"Kaiser Permanente","startDate":"2018-01-01","conditions":"Opiate Replacement Therapy","enrollment":2500},{"nctId":"NCT00555425","phase":"PHASE4","title":"Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2008-07","conditions":"Opiate Dependence","enrollment":113},{"nctId":"NCT01549652","phase":"NA","title":"5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence","status":"COMPLETED","sponsor":"Stanford University","startDate":"2011-04","conditions":"Opioid Withdrawal, Physical Dependence","enrollment":133},{"nctId":"NCT01517165","phase":"PHASE1","title":"Pioglitazone to Treat Opioid Withdrawal Symptoms","status":"TERMINATED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2012-01-04","conditions":"Opioid-Related Disorders","enrollment":24},{"nctId":"NCT01377610","phase":"PHASE1","title":"Improved Strategies for Outpatient Opioid Detoxification","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2011-06","conditions":"Opioid Dependence","enrollment":150},{"nctId":"NCT03063905","phase":"","title":"The Effects of Opioid Taper on Opioid-Induced Hyperalgesia","status":"TERMINATED","sponsor":"Georgetown University","startDate":"2017-01","conditions":"Buprenorphine, Pain","enrollment":15},{"nctId":"NCT03365817","phase":"PHASE3","title":"Cognitive Function and Addiction Under Opioid Tapering","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2009-02-02","conditions":"Chronic Pain, Opioid Use","enrollment":75},{"nctId":"NCT01895270","phase":"PHASE1, PHASE2","title":"Improving Buprenorphine Detoxification Outcomes With Isradipine","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2013-10","conditions":"Opioid Dependence","enrollment":28},{"nctId":"NCT02276989","phase":"PHASE2","title":"Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain","status":"WITHDRAWN","sponsor":"Georgetown University","startDate":"2014-12","conditions":"Compliance, Chronic Pain","enrollment":""},{"nctId":"NCT00326235","phase":"PHASE4","title":"Effects of Buspirone in Opiate Withdrawal","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2002-01","conditions":"Heroin Dependence","enrollment":""},{"nctId":"NCT01802515","phase":"NA","title":"A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment","status":"TERMINATED","sponsor":"Yale University","startDate":"2012-12","conditions":"Cocaine Dependence, Opiate Dependence","enrollment":14},{"nctId":"NCT01883882","phase":"NA","title":"Pilot Trial of Opioid Taper Support","status":"COMPLETED","sponsor":"University of Washington","startDate":"2013-06","conditions":"Chronic Non-cancer Pain","enrollment":35},{"nctId":"NCT01058642","phase":"PHASE2","title":"Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia","status":"TERMINATED","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2010-01","conditions":"Postherpetic Neuralgia","enrollment":41},{"nctId":"NCT00719095","phase":"PHASE2","title":"Effective Treatment for Prescription Opioid Abuse","status":"COMPLETED","sponsor":"University of Vermont Medical Center","startDate":"2006-04","conditions":"Prescription Opioid Dependence","enrollment":105}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":35,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Morphine, oxycodone, metadone, fentanyl, tramadol"],"phase":"phase_3","status":"active","brandName":"Opioids taper off","genericName":"Opioids taper off","companyName":"Rigshospitalet, Denmark","companyId":"rigshospitalet-denmark","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Opioids taper off through interventions such as Treatment as Usual, Telephonic Support, and DOTS Intervention, which are being studied in clinical trials for conditions like Opioid Use Disorder and Opioid Withdrawal. Opioids are small molecules that can be tapered off, as classified by the ChEMBL database, which provides information on their chemical properties and mechanisms.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}